Degradation of ginsenosides in humans after oral administration

Drug Metabolism and Disposition

Volumn 31, Issue 8, 2003, Pages 1065-1071

  Tawab, Mona Abdel ^a   Bahr, Ute ^a   Karas, Michael ^a   Wurglics, Mario ^a   Schubert Zsilavecz, Manfred ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE F1; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; PROTOPANAXADIOL; PROTOPANAXATRIOL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG EFFECT; DRUG EXCRETION; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG METABOLISM; GASTROINTESTINAL TRACT; GINSENOSIDE RF; HUMAN; HYDROLYSIS; MASS SPECTROMETRY; PILOT STUDY; PLASMA; PRIORITY JOURNAL; SCREENING; SYSTEMIC CIRCULATION; URINALYSIS;

ADMINISTRATION, ORAL; BIOTRANSFORMATION; CAPSULES; GINSENOSIDES; HUMANS; MASS SPECTROMETRY; SAPOGENINS; TRITERPENES;

ANIMALIA; BACTERIA (MICROORGANISMS); PANAX GINSENG;

EID: 0042526129     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.8.1065     Document Type: Article

References (24)

1. n) as a tool for rapid and sensitive analysis of ginsenosides and their galactosyl derivatives. Helv Chim Acta 83:739-747.
2. 1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay, Biol Pharm Bull 21:245-249.
3. 1 to compound K by Eubacterium sp. A44, a human intestinal bacterium and absorption of compound K. Ginseng Rev 24:1-7.
4. Attele AS, Wu JA, and Yuan C-S (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharm 58:1685-1693.
5. Bae EA, Choo MK, Park EK, Park SY, Shin HY, and Kim DH (2002) Metabolism of ginsenoside Rc and ist related antiallergic activity. Biol Pharm Bull 25:743-747.
6. 2 from human intestinal bacteria. Biol Pharm Bull 23:1481-1485.
7. Chang TKH, Chen J, and Benetton SA (2002) In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human, CYPA1, CYPA2 and CYPA3. Drug Metab Dispos 30:378-384.
8. Cui J-F, Björkhem I, and Eneroth P (1997) Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. J Chromatogr B Biomed Sci Appl 689:349-355.
9. Eliason BC, Kruger J, Mark D, and Rasman DN (1997) Dietary supplement users: demographic, product use and medical system interaction. J Am Board Fam Pract 10:265-271.
10. Gillis CN (1997) Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 54:1-8.
11. Gruenwald J and Buettel K (1996) The European Phytomedicines Market - Figures, Trends, Analyses. Drugs made in Germany. 39:6-11.
12. Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S, and Tanaka O (1982) Degradation of ginseng saponins under mild acidic conditions. Planta Med 44:146-149.
13. Harnack LJ, Rydall SA, and Stang J (2001) Prevalence of use of herbal products by adults in the Minneapolis/St. Paul, Minn, metropolitan area. Mayo Clin Proc 76:688-694.
14. Hasegawa H, Sung J-H, and Benno Y (1997) Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med 63:436-440.
15. Hasegawa H, Sung J-H, Matsumiya S, and Uchiyama M (1996) Main ginseng metabolites formed by intestinal bacteria. Planta Med 62:453-455.
16. Hollman PC, Bijsman MN, van Gameren Y, Cnossen EP, de Vries JH, and Katan MB (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 31:569-573.
17. 2 in the large intestine of rats. Chem Pharm Bull 38:2859-2861.
18. 1 in plasma of human after intake of red ginseng powder. Abstract of papers, 11th Symposium of the Medical Society for Red Ginseng Research, Kobe, Japan, p 36.
19. 1 in the rat. Chem Pharm Bull 31:292-298.
20. Scalbert A and Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-2085S
21. Shibata S (2001) Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 16(Suppl):S28-S37.
22. Soldati F (2000) Panax ginseng standardization and biological activity, in Biologically Active Natural Products: Pharmaceuticals (Cutler SJ and Cutler HG eds) pp 209-232. CRC Press LLC, Boca Raton, FL.
23. 1 by whole-body autoradiobiography and chromatography. Acta Pharm Suec 22:113-122.
24. Wolffram S, Block M, and Ader P (2002) Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr 132:630-635.